Quantcast
Channel: Drug Delivery Business
Browsing all 7 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Nanobiotix seeks to boost cancer care with nanoparticle-radiotherapy combo

Increasingly, pharma and biotech companies are looking towards personalized medicine to guide their portfolios, developing therapies designed to address the needs of individual patient populations....

View Article



Image may be NSFW.
Clik here to view.

Nanobiotix’s nanoparticle-immunotherapy trial wins FDA approval

Nanobiotix (EMA:NANO) said today that the FDA has approved its IND application for a cancer trial combining its radiotherapy-activated nanoparticle tech with an anti-PD1 antibody. The Phase I/II trial...

View Article

Image may be NSFW.
Clik here to view.

Nanobiotix inks $47m financing to support nanomedicine development

Nanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based...

View Article

Image may be NSFW.
Clik here to view.

Nanobiotix reels in $18.5m tranche from European Investment Bank

Nanobiotix (PAR:NANO.PA) received €16 million ($18.5 million) in the first tranche of a previously-announced non-dilutive loan from the European Investment Bank. The five-year funding deal is designed...

View Article

Image may be NSFW.
Clik here to view.

FDA clears Nanobiotix to start cancer treatment trial

Nanobiotix (PAR:NANO.PA) announced that the FDA designated its cancer treatment trial with the University of Texas MD Anderson Cancer Center as “safe to proceed.” The trial, co-developed by Nanobiotix...

View Article


Image may be NSFW.
Clik here to view.

Nanobiotix seeks to boost cancer care with nanoparticle-radiotherapy combo

Increasingly, pharma and biotech companies are looking towards personalized medicine to guide their portfolios, developing therapies designed to address the needs of individual patient populations....

View Article

Image may be NSFW.
Clik here to view.

Nanobiotix’s nanoparticle-immunotherapy trial wins FDA approval

Nanobiotix (EMA:NANO) said today that the FDA has approved its IND application for a cancer trial combining its radiotherapy-activated nanoparticle tech with an anti-PD1 antibody. The Phase I/II trial...

View Article
Browsing all 7 articles
Browse latest View live




Latest Images